Phase 2 Chronic Low Back Pain Study

Study Identifier
M12-807
CT.gov Identifier
NCT01364922
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Pain
    • Study Drug
  • hydrocodone/acetaminophen extended release
  • Placebo
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 75 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    Adult subjects who have a diagnosis of chronic low back pain of at least 6 month duration
    Exclusion Criteria:
    Subjects with a history of surgical or invasive intervention

    Protocol Summary

    The primary purpose of this study was to evaluate the analgesic effect and safety of hydrocodone/acetaminophen extended release compared to placebo.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 54875
    Tucson, Arizona, United States, 85704
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54876
    Anaheim, California, United States, 92801
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54877
    Burbank, California, United States, 91505
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54873
    Lomita, California, United States, 90717
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54874
    DeLand, Florida, United States, 32720
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 54866
    Oldsmar, Florida, United States, 34677
    Status
    Not applicable
    Showing {first} - {last} of {total} Results